• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

manufacturing

WuXi
CRO

WuXi AppTec posts sales decline but picks up new business in Q3

With the specter of the BIOSECURE Act clouding its future, China’s WuXi AppTec sustained its fourth straight quarter with a revenue decline.
Kevin Dunleavy Oct 29, 2024 8:25am
Braslia Federal District Brazil view of Lake Parano with government buildings and the Cathedral

GEMMABio gene therapy heads to Brazil with $100M government deal

Oct 8, 2024 1:43pm
ringing alarm clock times up

100 days with John Crowley: Behind BIO’s new structure & vision

Jun 25, 2024 9:05am
Galway Ireland Coast Connemara

Dexcom kicks off first European manufacturing facility

Jan 19, 2024 10:15am
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

Moderna could be open to out-licensing if sales struggle: Bancel

Nov 2, 2023 11:09am
FDA stop sign

Nurix's cancer drug on partial hold while manufacturing upgraded

Nov 2, 2023 8:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings